Difference between revisions of "Levamisole (Ergamisol)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "Category:Discontinued" to "Category:Discontinued drugs") |
m |
||
Line 3: | Line 3: | ||
*[[Colon cancer]] | *[[Colon cancer]] | ||
*[[Rectal cancer]] | *[[Rectal cancer]] | ||
+ | ==History of changes in FDA indication== | ||
+ | *6/18/1990: indicated as adjuvant treatment in combination with [[Fluorouracil (5-FU)|5-fluorouracil]] after surgical resection in patients with Dukes' stage C [[colon cancer]]. | ||
+ | |||
==Also known as== | ==Also known as== | ||
*'''Brand name:''' Ergamisol | *'''Brand name:''' Ergamisol |
Revision as of 13:58, 17 September 2020
This agent is not commercially available in the United States and is included for historic purposes only.
Diseases for which it was used
History of changes in FDA indication
- 6/18/1990: indicated as adjuvant treatment in combination with 5-fluorouracil after surgical resection in patients with Dukes' stage C colon cancer.
Also known as
- Brand name: Ergamisol